Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
Clinical trial NCT02376296 · COMPLETED
Trial details
- NCT number
- NCT02376296
- Sponsor
- Saladax Biomedical, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-02-01
- Primary completion
- 2018-02-10
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.